Aligos therapeutics announces presentations at the jefferies virtual london healthcare conference & the piper sandler annual healthcare conference

South san francisco, calif., nov. 13, 2020 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that management will be participating in two upcoming virtual investor conferences and invites investors to participate by webcast. please see additional details below:
ALGS Ratings Summary
ALGS Quant Ranking